共 50 条
- [42] Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials Rheumatology and Therapy, 2022, 9 : 1517 - 1529
- [44] RAPID3 (Routine Assessment of Patient Index Data 3) Severity Categories and Response Criteria: Similar Results to DA528 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) Clinical Trial of Certolizumab Pegol ARTHRITIS CARE & RESEARCH, 2011, 63 (08) : 1142 - 1149
- [48] Patient Reported Disease Activity including Joint Assessment: A Comparison of RADAI (Rheumatoid Arthritis Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) in Patients Treated with Certolizumab Pegol Over 12 Weeks JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1707 - 1708
- [50] Patient-Reported Disease Activity Including Joint Assessment: A Comparison of RADAI (Rheumatoid Arthritis Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) in Patients Treated with Certolizumab Pegol Over 12 Weeks ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S480 - S481